alvac-hiv vaccine
Vaccineexperimental
Clinical trial activity
8 trials · 20 clinical orgs · 0 marketing orgs
Phase 1
6
Phase 2
5
Phase 3
1
Phase 4
0
Earliest trial started Nov 2, 1999 (NCT00001090)
Timeline
Indications
Studied for
Mechanism of action
- Human immunodeficiency virus type I enhancer-binding protein 1Immunity, active
HIVEP1 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- alvac
- alvac-hiv mn120tmg
- alvac-hiv vaccine
- alvac vih 1433
- vcp2438
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03284710 | Phase 1/Phase 2 (Phase 2) | Jun 19, 2017 | Centre for the AIDS Programme of Research in South Africa, GlaxoSmithKline, HIV Vaccine Trials Network, National Institute of Allergy and Infectious Diseases (NIAID), Sanofi-Aventis, University of Alabama, Birmingham |
| NCT03122223 | Phase 1/Phase 2 (Phase 2) | Jun 5, 2017 | GlaxoSmithKline, National Institute of Allergy and Infectious Diseases (NIAID), Sanofi-Aventis, University of California, San Francisco |
| NCT02968849 | Phase 2/Phase 3 (Phase 3) | Oct 1, 2016 | Bill and Melinda Gates Foundation, GlaxoSmithKline, National Institute of Allergy and Infectious Diseases (NIAID), Sanofi, University of the Witwatersrand |
| NCT02404311 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2015 | Bill and Melinda Gates Foundation, HIV Vaccine Trials Network, Medical Research Council, National Institute of Allergy and Infectious Diseases (NIAID), Novartis, Sanofi-Aventis |
| NCT00212888 | Phase 1/Phase 2 (Phase 2) | Apr 1, 2004 | Canadian Institutes of Health Research (CIHR), CIHR Canadian HIV Trials Network, Ontario HIV Treatment Network, University of Ottawa |
| NCT00894114 | Phase 1 | May 1, 2003 | Merck |
| NCT00196651 | Phase 2 | Aug 1, 2000 | Assistance Publique - Hôpitaux de Paris, Aventis, French National Agency for Research on AIDS and Viral Hepatitis |
| NCT00001090 | Phase 1 | Nov 2, 1999 | National Institute of Allergy and Infectious Diseases (NIAID) |
Showing 8 of 8 trials
Page 1 / 1
Organizations
Research & Development (20)
20 organizations
Page 1 / 1